Deptt.of Pharmacology PGI Organise 34th NATIONAL WORKSHOP ON CLINICAL PHARMACOLOGY

By 121 News Reporter

Chandigarh 24^th March:-- The 34th National Workshop on Clinical Pharmacology was organized by the Department of Pharmacology, PGI, Chandigarh began today. The workshop was inaugurated by Prof Y. K. Chawla, Director, PGIMER. The Head of the department Prof. A. Rajwanshi welcomed the delegates and informed that in this workshop nearly 65 delegates from all over India are participating. Prof. Rajwanshi further informed that the delegates include faculty members as well as students undergoing their postgraduate training.

 Emeritus Professor P.L. Sharma, Former Dean PGI introduced the delegates to the aims and objectives of the workshop and encouraged delegates for actively participating in discussions for the success of the workshop. Professor V S Mathur, former faculty at PGIMER and Behrin, discussed about evolution of discipline of clinical pharmacology in India, highlighting the contributions in the field made by the Clinical Pharmacology Department at PGIMER. He duly shared his experiences and sincere efforts made by the founder faculty members of the institute in bringing up the discipline in India. Dr.Samir Malhotra, Additional Professor of the department and Organizing Secretary of the Workshop, spoke on Preclinical toxicology studies. Dr. Nusrat Shafiq, Assistant Professor discussed on how an application for new drug (IND) must be submitted to the regularity authorities. She explained the process of new drug development and the required information for proceeding further.

Experts from pharmaceutical industry spoke about various aspects of new drug development.  Dr. Shoibal Mukherjee, vice president Quintiles (Head Asia Medical sciences group) discussed the national and international regulations governing clinical trials. He also discussed the issue of clinical trial compensation. The process for Exploratory and Confirmatory drug trials were elaborated by Dr. Monica Tandon , Head of clinical pharmacology, Ranbaxy and Dr. Rajan Mittal Associate Director, Global Medical Affairs Dr. Reddy’s Lab, respectively.